The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the
The model's full reasoning — Q2 2022 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management describe that a growing share of company's revenue now arrives without a new selling event — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has recently and visibly grown as proportion of business, with management grounding shift in observed current behavior and treating it as changing quality of revenue? We need use only transcript. Company is Surgery Partners, owns/operates surgical facilities. Revenue from surgical cases. Not typical recurring revenue. They discuss physician recruiting, cases, acquisitions. There is no mention of reorders, refills, renewals, repeat purchases, consumable pull-through. They mention "new physician recruiting efforts yielded 100 new recruits" etc. They discuss "new recruits" bringing cases. They discuss "same-facility revenues increased" with case growth and net revenue per case. They discuss "transition of procedures out of traditional acute care inpatient settings continues to accelerate." But that's not self-arriving revenue. They discuss "organic growth initiatives" and "physician recruitment" - but that's about winning new physicians. They mention "repeat" maybe? No. They mention "customers' own standing routines"? No. They mention "usage-driven billing"? No. They mention "installed base"? No. They mention "recurring revenue"? No. So answer NO. Need ensure no nuance: They discuss "new physician recruiting efforts" and "new recruits" bringing cases. That's new selling event. They discuss "same-facility" growth, but that's existing facilities, not necessarily self-arriving. They discuss "case growth" and "net revenue per case" - not recurring. They discuss "M&A" and "de novos" - not self-arriving. They discuss "ValueHealth partnership" - not recurring. They discuss "commercial contracting" - not self-arriving. They discuss "robotics" - not aftermarket. So NO. Final answer: NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.